Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hong Guo

Showing results (1261-1270 of 2,125) with videos related to

Pageof 213
Sort By:
International Immunopharmacology|May 30, 2013
Diepitope multiple antigen peptide of hTERT trigger stronger anti-tumor immune responses in vitroZhong-Li Liao, Gang Luo, Xia Xie, et al.
Biomed Research International|June 14, 2013
Sanguinarine inhibits vascular endothelial growth factor release by generation of reactive oxygen species in MCF-7 human mammary adenocarcinoma cellsXian-zhe Dong, Miao Zhang, Kun Wang, et al.
Hepatobiliary & Pancreatic Diseases International : HBPD INT|August 22, 2017
Interaction between insulin-like growth factor binding protein-related protein 1 and transforming growth factor beta 1 in primary hepatic stellate cellsXiu-Qing Li, Qian-Qian Zhang, Hai-Yan Zhang, et al.
Cancer Management and Research|September 5, 2020
Intratreatment Tumor Volume Change During Definitive Chemoradiotherapy is Predictive for Treatment Outcome of Patients with Esophageal CarcinomaRuihong Huang, Hong Guo, Jianzhou Chen, et al.
Frontiers in Oncology|January 6, 2023
Clinical efficacy of combination therapy of an immune checkpoint inhibitor with taxane plus platinum versus an immune checkpoint inhibitor with fluorouracil plus platinum in the first-line treatment of patients with locally advanced, metastatic, or recurrent esophageal squamous cell carcinomaYing Li, Yanyan Ji, Lin Shen, et al.
Cancer Management and Research|October 29, 2020
Vessel Size Imaging is Associated with IDH Mutation and Patient Survival in Diffuse Lower-Grade GliomaHouyi Kang, Peng Chen, Hong Guo, et al.
Oncology Reports|February 1, 2014
OCT3 and SOX2 promote the transformation of Barrett's esophagus to adenocarcinoma by regulating the formation of tumor stem cellsXingwei Wang, Shiming Yang, Xiaoyan Zhao, et al.
Asian Journal of Andrology|December 22, 2007
Assessment of released acrosin activity as a measurement of the sperm acrosome reactionRui-Zhi Liu, Wan-Li Na, Hong-Guo Zhang, et al.
Mycopathologia|May 13, 2014
Prevalent drug resistance among oral yeasts from asymptomatic patients in Hainan, ChinaJinyan Wu, Hong Guo, Guohui Yi, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|November 24, 2023
Tanshinone IIA normalized hepatocellular carcinoma vessels and enhanced PD-1 inhibitor efficacy by inhibiting ELTD1Dengxuan Mao, Hong Wang, Hong Guo, et al.
Pageof 213

Showing results (1261-1270 of 2,125) with videos related to

Sort By:
Pageof 213
International Immunopharmacology|May 30, 2013
Diepitope multiple antigen peptide of hTERT trigger stronger anti-tumor immune responses in vitroZhong-Li Liao, Gang Luo, Xia Xie, et al.
Biomed Research International|June 14, 2013
Sanguinarine inhibits vascular endothelial growth factor release by generation of reactive oxygen species in MCF-7 human mammary adenocarcinoma cellsXian-zhe Dong, Miao Zhang, Kun Wang, et al.
Hepatobiliary & Pancreatic Diseases International : HBPD INT|August 22, 2017
Interaction between insulin-like growth factor binding protein-related protein 1 and transforming growth factor beta 1 in primary hepatic stellate cellsXiu-Qing Li, Qian-Qian Zhang, Hai-Yan Zhang, et al.
Cancer Management and Research|September 5, 2020
Intratreatment Tumor Volume Change During Definitive Chemoradiotherapy is Predictive for Treatment Outcome of Patients with Esophageal CarcinomaRuihong Huang, Hong Guo, Jianzhou Chen, et al.
Frontiers in Oncology|January 6, 2023
Clinical efficacy of combination therapy of an immune checkpoint inhibitor with taxane plus platinum versus an immune checkpoint inhibitor with fluorouracil plus platinum in the first-line treatment of patients with locally advanced, metastatic, or recurrent esophageal squamous cell carcinomaYing Li, Yanyan Ji, Lin Shen, et al.
Cancer Management and Research|October 29, 2020
Vessel Size Imaging is Associated with IDH Mutation and Patient Survival in Diffuse Lower-Grade GliomaHouyi Kang, Peng Chen, Hong Guo, et al.
Oncology Reports|February 1, 2014
OCT3 and SOX2 promote the transformation of Barrett's esophagus to adenocarcinoma by regulating the formation of tumor stem cellsXingwei Wang, Shiming Yang, Xiaoyan Zhao, et al.
Asian Journal of Andrology|December 22, 2007
Assessment of released acrosin activity as a measurement of the sperm acrosome reactionRui-Zhi Liu, Wan-Li Na, Hong-Guo Zhang, et al.
Mycopathologia|May 13, 2014
Prevalent drug resistance among oral yeasts from asymptomatic patients in Hainan, ChinaJinyan Wu, Hong Guo, Guohui Yi, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|November 24, 2023
Tanshinone IIA normalized hepatocellular carcinoma vessels and enhanced PD-1 inhibitor efficacy by inhibiting ELTD1Dengxuan Mao, Hong Wang, Hong Guo, et al.
Pageof 213